LifeScan said yesterday that it entered into an agreement with Willis Towers Watson to expand the commercialization of its OneTouch Reveal Plus digital diabetes therapy system. The companies hope the collaboration will see LifeScan and Willis Towers Watson combine to support self-insured employers in helping their employees and dependents manage diabetes. The OneTouch Reveal Plus […]
LifeScan releases latest version of diabetes management app
LifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers. The newest version of LifeScan’s app includes notifications that automatically warn users of […]
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer of more than $2 billion from private equity shop Platinum Equity for its LifeScan blood glucose monitoring business as it moves toward the exit in the diabetes market. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, […]
Johnson & Johnson moves closer to exiting the diabetes business with $2.1B LifeScan sale
Johnson & Johnson (NYSE:JNJ) took another step toward the exit door for the diabetes business, agreeing to a $2,1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later […]
J&J’s LifeScan touts studies of OneTouch blood glucose monitoring system
Two recently-published studies of LifeScan‘s OneTouch Verio Flex blood glucose monitoring system showed that the technology is accurate, reliable and linked with improvements in glycemic control, the Johnson & Johnson (NYSE:JNJ) business touted today. The release comes just days after the healthcare giant revealed that it plans to shut down its Animas insulin pump business and review […]
Drug Delivery Business News
@DrugDeliveryNow
LinkedIn